Brief: Lantheus To Acquire Life Molecular Imaging For An Upfront Payment Of $350 Mln
13/01/2025 07:38
Jan 13 (Reuters) - Lantheus Holdings Inc LNTH.O :
* LANTHEUS TO ACQUIRE LIFE MOLECULAR IMAGING FOR AN UPFRONT
PAYMENT OF $350 MILLION TO ACCELERATE INNOVATION FOR PATIENTS IN
THE GROWING ALZHEIMER’S DISEASE RADIODIAGNOSTIC MARKET
* LANTHEUS HOLDINGS INC - TRANSACTION EXPECTED TO BE
ACCRETIVE TO
ADJUSTED EPS WITHIN 12 MONTHS
* LANTHEUS HOLDINGS INC - DEAL INCLUDES $350 MILLION UPFRONT
AND
UP TO $400 MILLION IN EARN-OUT PAYMENTS
Source text: ID:nGNX70rGrk
Further company coverage: LNTH.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say